Regentis Biomaterials RGNT
NYSE RGNT
$1.85 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:36 PM EDT

Regentis Biomaterials (RGNT) Non-Current Assets (2026)

Updated

Regentis Biomaterials' Non-Current Assets came in at $64,000 for Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Non-Current Assets (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 89.81 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 84.70 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 78.99 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 11.33 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 68.92 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 33.51 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 37.24 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 7.05 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 42.59 Bn
10 Regentis Biomaterials 1.08 Mn -7.87 Mn - 64,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 64,000.00
API Access

Regentis Biomaterials Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RGNT&period=max&api_key=YOUR_API_KEY